Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/APRE/Gross profit

Aprea Therapeutics, Inc. (APRE) Gross profit

Aprea Therapeutics, Inc. (APRE) annual gross profit history from SEC filings — each fiscal year as reported.

No annual history for this metric yet

The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.

← Back to APRE

Source: SEC XBRL filings · For reference only · Not investment advice

More APRE financial trends

APRE RevenueAPRE Net incomeAPRE Net marginAPRE Gross marginAPRE Operating incomeAPRE Operating marginAPRE Operating cash flowAPRE Free cash flowAPRE Capital expendituresAPRE Return on equityAPRE Stock buybacksAPRE Dividends paidAPRE Total assetsAPRE Total liabilitiesAPRE Shareholders’ equityAPRE overview →